PDF-NATIONAL PUBLIC HEALTH AGENDA FOR LUPUS
Author : sophia2 | Published Date : 2021-06-18
A BLUEPRINT FOR ACTION 2015 This publication was supported by Cooperative Agreement Number 5U38OT0002502 from the Centers for Disease Control and PreventionIts contents
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "NATIONAL PUBLIC HEALTH AGENDA FOR LUPUS" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
NATIONAL PUBLIC HEALTH AGENDA FOR LUPUS: Transcript
A BLUEPRINT FOR ACTION 2015 This publication was supported by Cooperative Agreement Number 5U38OT0002502 from the Centers for Disease Control and PreventionIts contents are solely the responsibility. 3337. Thursday. , . June 12, 2014, 9:30 . a.m.. San Francisco, . CA. . Commissioners:. Michael R. . Peevey . Michel . Peter . Florio. Catherine . J.K. Sandoval. Carla . J. . Peterman. . Dr. : Mohamed . Abdelhafez. . . . . Nephrology specialist . . MNGH. Agenda. DEFINITION AND EPIDEMIOLOGY. ETIOLOGY AND PATHOGENESIS. RENAL AND EXTRARENAL MANIFESTATIONS. IMMUNOLOGIC TESTS IN LUPUS NEPHRITIS. Complementary and Alternative Medicine. Vitamins A, C, E and D. Cardiovascular disease in lupus. Benefits of certain diets, omega 3. Herbal Supplements. Disclaimer: No specific diet for the treatment of SLE exists at this time. Presented by Camille Keenan, MS3 . & Matthew Covey, MS3. at Pediatric Neurology Grand Rounds. Friday, October 3, . 2014. Mentor: Ian J. Butler, MD. Chief complaint. Child 1. Full term African American female born with red and scaly butterfly rash. . History. Classical. Middle Ages. 12. th. century physician . Rogerius. Neoclassical. Moric. Kaposi. Modern. 1948 . discovery of the LP cell. History cont. . First Medications. 1894. Quinine. Salicylates. Donald L . Kimpel. , MD. . March 28, 2015. Sentara Medical Center. LFA-DMV . The Many features and. “flavors” of Systemic Lupus. 11 ACR criteria. ACR ~= SLICC. Plaquenil. Eye Testing. . . Diabetes and Lupus. . Challenges and Options . Grand . Rounds. Presented by:. Sumona Kabir, DO. January 21. st. , 2015 . Overview . Case presentation. Definition of SLE. Pathophysiology. Classification . Details of each classification. What causes Lupus? Genes No gene or group of genes has been proven to cause lupus. Lupus does, however, appear in certain families, and when one of two identical twins has lupus, there is an increased disease that ravages dierent parts of the body. Research shows lupus is more pervasive and more severe than people think, and has an impact that the public doesnt realize. You can change t n e F l a r e R e m i s s i o Do I havLupus? March 2003 Suzi WojdyslawskiYOUT andPRINTING: Table of Contents alk About Lupus . . . . . . . . . . . . . . . . .1Take Care and Take Action . . . . . . . . LupusSLE OverviewChronic inflammatory autoimmune disease with unknown etiologyPossible provocative agents UV light infections hormones drugs emotional or physical stress genetic factors involvedEpide Dimitrios. T. . Boumpas. (. leader. ), George Bertsias (. facilitator. ), on behalf of the Study Group members. The EULAR study Group on SLE was established in 2011 and has the following . objectives. Download PDF Natural Lupus Treatment System™ eBook by Dr. Gary M. Levin - a comprehensive package for people suffering from autoimmune diseases like lupus. Dr.Harish. Sivagnanam, Dr. . Ramasubramanian.V. , . Dr.Kannan. . Bhaba.V. , . Dr.P.K.Senthil. Kumar, . Dr.Murugesh. Anand. Tirunelveli Medical College and Hospital , Tirunelveli. BACKGROUND . Systemic Lupus Erythematosus(SLE) is a common autoimmune disorder which involves multiple systems. Even though it’s a common disorder of women in their reproductive age , It can occur across all ages and genders. Kidney is involved in almost 38 % of the patients with SLE. 40 to 60 % of patients have overt findings at the time of diagnosis . Patients with SLE can have antiphospholipid antibodies (.
Download Document
Here is the link to download the presentation.
"NATIONAL PUBLIC HEALTH AGENDA FOR LUPUS"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents